Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REWORD-HF
2009-014769-16Phase 4Terminated
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dopamine and furosemide in heart failure (HF) (3 arms), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoints: Clinical and laboratory improvement at 96 hours and Admission-free survival at 90 days. Started Nov 2009; status: terminated.
02
Drugs
dopaminefurosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2009-014769-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014769-16.